• 02 Jul, 2025

Suggested:

Bayer site in Frankfurt is facing closure.

Asia is flooding the market with cheap generics. Therefore, Bayer wants to restructure its agricultural business and focus on research and high-tech. For the first time, a German plant would be closed for this purpose.

Asia is flooding the market with cheap generics. In response, Bayer plans to restructure its agricultural business and focus on research and high-tech. This would mark the first time a German plant would be closed.

Bayer appears to be considering closing its site in Frankfurt with 500 jobs. The lights could go out there by the end of 2028, according to Bild newspaper. Bayer cites the price pressure from Asian competitors flooding the market with their cheap generics as reasons. "Their prices are sometimes below the production costs in Europe," says the corporate management. Strict legal requirements further burden the European location.

Therefore, Bayer aims to shift from quantity to quality, Bild reports. Instead of generic crop protection products, innovative technologies and high-tech products are set to become the new flagship. The agriculture sector will be completely restructured for this purpose.

Research and development will be consolidated in Monheim am Rhein in the future. Production at the Dormagen site near Leverkusen will be streamlined. Around 200 positions out of almost 1200 will be cut there.

The union is outraged. It calls the closure plans a "turning point in the 162-year corporate history." They also contradict Bayer's declared commitment to its home base in Germany. In fact, the decision would be unprecedented: for the first time, a German site would be abandoned.